Ann: ResMed Announces Results for the First Quarter of FY2024, page-3

  1. 69 Posts.
    lightbulb Created with Sketch. 4
    tend to agree. Result seems ok but disappointing to see decline in margins again. Overall not strong enough to see a rebound in the share price. I note they also have plans to commence share repurchase which makes a lot of sense and should be done at scale.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$40.92
Change
0.750(1.87%)
Mkt cap ! $23.86B
Open High Low Value Volume
$40.80 $41.09 $40.71 $31.49M 769.5K

Buyers (Bids)

No. Vol. Price($)
1 1000 $40.90
 

Sellers (Offers)

Price($) Vol. No.
$41.00 772 3
View Market Depth
Last trade - 16.13pm 23/07/2025 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.